This ADC product is comprised of an anti-SDC1 monoclonal antibody (nBT062) conjugated via a SPDB linker to a DM4. The DM4 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the ce
* VAT and and shipping costs not included. Errors and price changes excepted